- Report
- December 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- September 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- September 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- September 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- August 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- August 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- September 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- August 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- August 2025
- 150 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- April 2026
- 145 Pages
Global
From €3500EUR$4,188USD£3,110GBP
- Report
- April 2026
- 144 Pages
Global
From €3500EUR$4,188USD£3,110GBP
- Report
- September 2025
- 101 Pages
Global
From €3500EUR$4,188USD£3,110GBP
- Report
- May 2026
- 135 Pages
Global
From €4342EUR$4,850USD£3,728GBP
- Report
- November 2025
- 120 Pages
United States
From €3536EUR$3,950USD£3,036GBP
- Report
- May 2026
- 110 Pages
United States
From €4252EUR$4,750USD£3,651GBP
- Report
- March 2026
- 239 Pages
United States
From €4342EUR$4,850USD£3,728GBP
- Report
- July 2023
- 115 Pages
Global
From €3447EUR$3,850USD£2,959GBP
- Report
- May 2025
- 107 Pages
United States
- Report
- February 2021
- 420 Pages
United States
From €2149EUR$2,400USD£1,845GBP
- Report
- May 2025
- 100 Pages
Global
From €5327EUR$5,950USD£4,573GBP

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more